
Rigetti Computing (RGTI) Stock Forecast & Price Target
Rigetti Computing (RGTI) Analyst Ratings
Bulls say
Rigetti Computing is viewed favorably because it is demonstrating tangible technical progress while keeping its commercialization roadmap intact, including achieving 99.5% median two-qubit gate fidelity on the Cepheus-1-108Q system and validating its chiplet-based architecture across interconnected 9Q units. The company also has near-term revenue catalysts, with the 108Q C-DAC system on track for delivery and revenue recognition by 4Q26, management targeting 4-6 system sales in 2027, and FY26 revenue expected to approximate $20.0MM. Its balance-sheet support is strengthened by up to $100MM in U.S. DoC funding, which should help finance key roadmap priorities such as cryogenics, readout miniaturization, and higher-connectivity chip designs.
Bears say
Rigetti Computing is viewed negatively because its business remains deeply loss-making, with Sep-Q revenue of $1.4MM against an adjusted EBITDA loss of $(7.2)MM, while bookings fell about 68% q/q and free cash flow stayed sharply negative. The company also faces heavy capital needs, with capex consuming 263% of sales in one period and roughly $200M in fab buildouts estimated over the next three years, which raises the risk of dilution through secondary offerings or convertible debt. Execution risk is compounded by delayed quantum adoption, supply chain setbacks that pushed back the 1000-Q and 4000-Q roadmaps by one year, and intense competition from better-funded rivals that could outlast a prolonged quantum winter.
This aggregate rating is based on analysts' research of Rigetti Computing and is not a guaranteed prediction by Public.com or investment advice.
Rigetti Computing (RGTI) Analyst Forecast & Price Prediction
Start investing in Rigetti Computing (RGTI)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Rigetti Computing (RGTI) Forecast
Rigetti Computing (RGTI) Analyst Forecast & Price Prediction
Start investing in Rigetti Computing (RGTI)
Order type
Buy in
Order amount
Est. shares
0 shares